Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Inventory (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Change in Inventory for 4 consecutive years, with -$8737.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory fell 98.34% to -$8737.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $9871.0, a 36.13% decrease, with the full-year FY2024 number at $9124.0, down 29.51% from a year prior.
  • Change in Inventory was -$8737.0 for Q3 2025 at bioAffinity Technologies, down from $5189.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $20281.0 in Q2 2024 to a low of -$8997.0 in Q1 2024.
  • A 4-year average of $2348.9 and a median of $58.0 in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: soared 5000.57% in 2023, then plummeted 2182.38% in 2024.
  • bioAffinity Technologies' Change in Inventory stood at -$175.0 in 2022, then skyrocketed by 5000.57% to $8576.0 in 2023, then crashed by 73.82% to $2245.0 in 2024, then crashed by 489.18% to -$8737.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Change in Inventory are -$8737.0 (Q3 2025), $5189.0 (Q2 2025), and $11174.0 (Q1 2025).